Total Visits

Views
Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts108

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts31671872

File Visits

Views
bitstream_12989.pdf40

Top country views

Views

Top cities views

Views